This research intends to examine the clinical characteristics and genetic diversity of a child experiencing epilepsy with myoclonic-atonic seizures (EMAS) attributed to a variant in the SLC6A1 gene. Here, SLC6A1 is linked to epilepsy with myoclonic atonic seizures.